Decentralizing gene and cell therapy manufacturing: changing tides or uphill battle
Year: 2024
Type: article
Abstract: “A concerted effort must be made to decentralize manufacturing, particularly for autologous products, and to adapt the regulatory framework to reflect the unique nature of [cell and gene] therapies.”
Source: Cell and Gene Therapy Insights
Author: Magdi Elsallab
Institutions: Harvard University, Massachusetts General Hospital
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4417368869
FWCI:
Cites:
Cited by:
Related to: